| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 12/11/2003 | WO2003101932A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/11/2003 | WO2003101928A1 Novel ligands that are inhibitors of the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 12/11/2003 | WO2003101471A1 Calcium-containing composition from bone tissue |
| 12/11/2003 | WO2003101453A1 Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 12/11/2003 | WO2003101374A2 Use of new etonogestrel esters |
| 12/11/2003 | WO2003087090A3 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 12/11/2003 | WO2003080630A3 Phosphate transport inhibitors |
| 12/11/2003 | WO2003057666A3 Inhibitors of dipeptidyl peptidase iv |
| 12/11/2003 | WO2003057202A8 Use of a gsk-3beta inhibitor in the manufacture of a medicament for increasing bone formation |
| 12/11/2003 | WO2003053163A3 Salt composition with low sodium chloride and high organic potassium salt content and uses thereof |
| 12/11/2003 | WO2003037266A3 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity |
| 12/11/2003 | WO2003026579A3 Combination therapies for immune mediated diseases |
| 12/11/2003 | WO2003024958A3 Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles |
| 12/11/2003 | WO2003024926A3 Methods and compositions of novel triazine compounds |
| 12/11/2003 | WO2003024395A3 Linked biaryl compounds |
| 12/11/2003 | WO2003022216A3 Biaryl substituted purine derivatives as potent antiproliferative agents |
| 12/11/2003 | WO2003017940A3 Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption |
| 12/11/2003 | WO2003011895A8 Compositions and methods for modulation of immune responses |
| 12/11/2003 | WO2003011226A3 Products and drug delivery vehicles |
| 12/11/2003 | WO2002087508A3 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 12/11/2003 | WO2002062778A3 Anti-thrombotic compounds, production and use thereof as medicaments |
| 12/11/2003 | US20030229226 Cathepsin cysteine protease inhibitors |
| 12/11/2003 | US20030229208 Humanized immunoglobulins |
| 12/11/2003 | US20030229148 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 12/11/2003 | US20030229118 Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation |
| 12/11/2003 | US20030229116 Enamine derivatives |
| 12/11/2003 | US20030229110 Cell signal transduction |
| 12/11/2003 | US20030229109 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 12/11/2003 | US20030229088 Novel methods and compositions for alleviating pain |
| 12/11/2003 | US20030229084 Osteoporosis; antiarthritic agents |
| 12/11/2003 | US20030229083 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 12/11/2003 | US20030229080 Cardiovascular disorders; sexual disorders |
| 12/11/2003 | US20030229075 Induce immunology response; genetic engineering; gene expression; crystallization |
| 12/11/2003 | US20030229072 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents |
| 12/11/2003 | US20030229067 Sedative, vasodilation, antiarrhythmia agents, antiallergens, antiinflammatory agents |
| 12/11/2003 | US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance |
| 12/11/2003 | US20030229047 Liquid formulation of decitabine and use of the same |
| 12/11/2003 | US20030229044 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease |
| 12/11/2003 | US20030229041 Administering steroid compound |
| 12/11/2003 | US20030229023 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents |
| 12/11/2003 | US20030228365 Pharmaceutical formulation |
| 12/11/2003 | US20030228353 Wound heraling agents; polypeptide |
| 12/11/2003 | US20030228292 Methods of inducing or enhancing connective tissue repair |
| 12/11/2003 | US20030228257 Induction apoptosis; antiarthritic agents |
| 12/11/2003 | CA2488270A1 Paramyxoviral vectors encoding antibodies, and uses thereof |
| 12/11/2003 | CA2487928A1 Pthrp-based prediction and diagnosis of bone disease |
| 12/11/2003 | CA2487688A1 Piperidine derivative, process for producing the same, and use |
| 12/11/2003 | CA2487679A1 Inhibitors of jak and cdk2 protein kinases |
| 12/11/2003 | CA2487636A1 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 12/11/2003 | CA2487293A1 Use of new etonogestrel esters |
| 12/11/2003 | CA2484451A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/11/2003 | CA2483817A1 Novel ligands that are inhibitors of the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 12/10/2003 | EP1369491A1 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 12/10/2003 | EP1369421A1 Pharmaceutical compositions comprising 2,3-Diaryl-pyrazolo[1,5-B]pyridazine derivatives |
| 12/10/2003 | EP1369119A1 Il-12 expression controlling agents |
| 12/10/2003 | EP1368660A2 Assay |
| 12/10/2003 | EP1368648A2 Detection of compounds that modulate inflammatory responses |
| 12/10/2003 | EP1368487A1 Methods involving the use of capg as a diagnostic marker and methods for the identification of capg modulators for the treatment and prevention of osteoporosis and related disease states |
| 12/10/2003 | EP1368473A2 Neurotransmission-associated proteins |
| 12/10/2003 | EP1368470A2 Transcriptional mediators of blood vessel development and endothelial differentiation |
| 12/10/2003 | EP1368458A2 Interferon-alpha induced gene |
| 12/10/2003 | EP1368357A1 Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds |
| 12/10/2003 | EP1368354A1 Modulators of chemokine receptor activity |
| 12/10/2003 | EP1368349A1 Xanthine derivative, production and use thereof as a medicament |
| 12/10/2003 | EP1368327A1 Benzo thiadiazine matrix metalloproteinase inhibitors |
| 12/10/2003 | EP1368324A1 Quinazolines as mmp-13 inhibitors |
| 12/10/2003 | EP1368323A1 Pyrimidine matrix metalloproteinase inhibitors |
| 12/10/2003 | EP1368318A2 Calcilytic compounds |
| 12/10/2003 | EP1368317A1 Tryptase inhibitors |
| 12/10/2003 | EP1368314A1 N-4-piperidinyl compounds as ccr5 modulators |
| 12/10/2003 | EP1368312A1 Benzo'f!isoindole derivatives with affinity to the ep4 receptor |
| 12/10/2003 | EP1368308A1 Cannabinoid receptor ligands |
| 12/10/2003 | EP1368037A2 Estrogen replacement therapy |
| 12/10/2003 | EP1368031A2 Method of treating of demyelinating diseases or conditions |
| 12/10/2003 | EP1368029A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails |
| 12/10/2003 | EP1368005A2 Chronotherapeutic dosage forms |
| 12/10/2003 | EP1368000A2 Chronotherapeutic dosage forms containing glucocorticosteroid |
| 12/10/2003 | EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| 12/10/2003 | EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 12/10/2003 | EP1276477B1 Medicaments containing pantothenic acid for the treatment of inflammatory joint disease |
| 12/10/2003 | EP1148897B1 Methods and compositions for healing and repair of articular cartilage |
| 12/10/2003 | EP1083889B1 Tetrahydronaphtalene compounds and their use for the treatment of neurodegenerative diseases |
| 12/10/2003 | EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 12/10/2003 | EP0964870B1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications |
| 12/10/2003 | EP0666914B1 Novel p-selectin ligand protein |
| 12/10/2003 | CN1461310A ANtibodies that bind human interleukin-18 and methods of making and using |
| 12/10/2003 | CN1461207A Vaginal delivery of bisphosphonates |
| 12/10/2003 | CN1460684A Epimedium extract and its production method |
| 12/10/2003 | CN1460498A Bone-strengthening medicine, tablet, capsule and oral liquor and preparation method thereof |
| 12/10/2003 | CN1130358C Imidzzole compounds and preparing method and application thereof |
| 12/10/2003 | CN1130223C Pharmaceutical formulation containing growth hormone, amino acid and non-ionic detergent |
| 12/10/2003 | CN1130220C Chinese medicine 'Ershefengshiwan' |
| 12/10/2003 | CN1130207C Ointment for bone injury and its preparing method |
| 12/09/2003 | US6660891 Methods for the production of D-chiro-inositol and the use of D-chiro inositol obtained therefrom |
| 12/09/2003 | US6660843 Fusion of Fc domains with biologically active peptides |
| 12/09/2003 | US6660839 Tumor necrosis related receptor, TR7 |
| 12/09/2003 | US6660767 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof |
| 12/09/2003 | US6660760 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 12/09/2003 | US6660748 1-azabicyclo(2.2.1)heptane or quinuclidine derivatives; treating or preventing neuronal damage associated with neurological diseases |
| 12/09/2003 | US6660744 Pyrazolopyrimidines as therapeutic agents |